Figure 7From: Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells Effects of bufalin on AKT and pAKT (Ser 473) expression in hepatoma cells. (A) HCCLM3 and HepG2 cells were treated with bufalin (100 nmol/L) and LY294002 (10 mmol/L) for the indicated times. GAPDH was used as a loading control. (B) Quantitative analysis of expression of AKT and pAKT (Ser 473). Columns represent the mean of three individual experiments performed in triplicate; error bars represent SD; LY represent LY294002. **P < 0.01, vs. controls.Back to article page